TS-1 as first-line therapy for gastric linitis plastica: historical control study.

Abstract

Gastric linitis plastica (LP) is usually found as an advanced gastric cancer and has a poor prognosis. No sufficiently effective chemotherapy has been reported. In recent years, TS-1 has yielded a high response rate for advanced gastric cancers and favorable treatment results have also been suggested for gastric LP. We retrospectively compared and discussed anti-tumor effects and survival time for 62 consecutive patients with unresectable gastric LP who underwent chemotherapy at Kitasato University East Hospital between November 1995 and December 2002. They were divided into two groups: 19 patients given chemotherapy including TS-1 as first-line therapy (TS-1 group), and 43 patients given chemotherapy mainly with 5-fluorouracil, cisplatin, methotrexate and mitomycin C (non-TS-1 group). The overall response was 57.9% [95% confidence interval (CI) 35.7-80.1%] in the TS-1 group, which was significantly greater than the 27.9% (95% CI 14.5-41.3%) of the non-TS-1 group (P < 0.01). The median survival time was 402 days (95% CI 251-553 days) in the TS-1 group, which was also significantly longer than the non-TS-1 group (213 days, 95% CI 165-261 days, P < 0.01). Neutropenia and febrile neutropenia of grade 3 or higher were observed in 21.1 and 5.2%, respectively, in the TS-1 group, which were lower than the values of 37.2 and 20.9% in the non-TS-1 group. We conclude that greater anti-tumor effects and longer survival time can be expected from chemotherapy including TS-1 for gastric LP compared with conventional chemotherapy.

• Authors: Tohru Sasaki, Wasaburo Koizumi, Satoshi Tanabe, Katsuhiko Higuchi, Norisuke Nakayama, Katsunori Saigenji
• Journal: Anti-cancer drugs (Anticancer Drugs) Vol. 17 Issue 5 Pg. 581-6 (Jun 2006) ISSN: 0959-4973 [Print] England
• PMID: 16702816 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Drug Combinations
• Pyridines
• S 1 (combination)
• Tegafur
• Mitomycin
• Oxonic Acid
• Cisplatin
• Fluorouracil
• Methotrexate

Topics

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
• Cisplatin (administration & dosage, adverse effects)
• Drug Combinations
• Female
• Fluorouracil (administration & dosage, adverse effects)
• Humans
• Linitis Plastica (drug therapy, mortality, pathology)
• Male
• Methotrexate (administration & dosage, adverse effects)
• Middle Aged
• Mitomycin (administration & dosage, adverse effects)
• Oxonic Acid (administration & dosage, adverse effects)
• Pyridines (administration & dosage, adverse effects)
• Retrospective Studies
• Stomach Neoplasms (drug therapy, mortality, pathology)
• Survival Analysis
• Tegafur (administration & dosage, adverse effects)